AZ Funded Non-clinical PhD Studentship (Fixed Term) in Selective Nanoparticle Targeting of Senescent Alveolar Epithelium Using an Alveolar Organoid Model
University of Cambridge · United Kingdom
Four-year PhD developing nanoparticles that target senescent alveolar type 2 cells, tested in human alveolar organoids, jointly supervised at the Cambridge Institute of Medical Research and AstraZeneca's Cambridge Discovery Centre. Suits a cell-biology-oriented graduate interested in lung disease an
Medicine & Clinical Sciences11h ago
